EMEA-000927-PIP01-10-M06
Key facts
| Invented name |
Constella
|
| Active substance |
linaclotide
|
| Therapeutic area |
Gastroentology-Hepatology
|
| Decision number |
P/0216/2021
|
| PIP number |
EMEA-000927-PIP01-10-M06
|
| Pharmaceutical form(s) |
Capsule, hard
|
| Condition(s) / indication(s) |
Treatment of functional constipation
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Allergan Pharmaceuticals International Limited
E-mail: ml-eu_reg_affairs@allergan.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|